Robin Cook: Cure (UK 2011)

From the Publisher:
The next book from the master of the medical thriller genre
With her young son's potentially fatal neuroblastoma in complete remission, New York City medical examiner Laurie Montgomery returns to work at the Office of Chief Medical Examiner. Worried that she still has what it takes, Laurie finds her first case back to be a dangerous puzzler, involving organized crime and two start-up bio-tech companies caught in a zero-sum game.

Satoshi Machita, a former Kyoto University researcher, is set to own a valuable patent controlling pluripotent stem cells destined to spark a trillion-dollar industry of regenerative medicine. When he dies on a crowded New York subway platform, Laurie must decide whether his death was natural - or something fiendish.

Behind the scenes, there are people who would like to see Laurie as far away from the investigation as possible. Despite threats against her, Laurie presses on, until they extend to the person she loves most in the world: her son, JJ. Suddenly Laurie must face solving the crime - and saving her son's life.

Robin Cook: Cure. Pan, ISBN: 9780330523820 (October, 2011), 459 p., £6.99.

Robin Cook: Cure (USA 2011)

From the Publisher:
With her son's illness in complete remission, New York City medical examiner Laurie Montgomery returns to work-and finds her first case back to be a dangerous puzzle of the highest order, involving organized crime and two start-up biotech companies caught in a zero-sum game...

Robin Cook: Cure. Berkley Books, ISBN: 9780425242605 (July, 2011), 503 p., $9.99.

Robin Cook: Cure (UK 2011)

From the Publisher:
The next book from the master of the medical thriller genre
With her young son's potentially fatal neuroblastoma in complete remission, New York City medical examiner Laurie Montgomery returns to work at the Office of Chief Medical Examiner. Worried that she still has what it takes, Laurie finds her first case back to be a dangerous puzzler, involving organized crime and two start-up bio-tech companies caught in a zero-sum game.

Satoshi Machita, a former Kyoto University researcher, is set to own a valuable patent controlling pluripotent stem cells destined to spark a trillion-dollar industry of regenerative medicine. When he dies on a crowded New York subway platform, Laurie must decide whether his death was natural - or something fiendish.

Behind the scenes, there are people who would like to see Laurie as far away from the investigation as possible. Despite threats against her, Laurie presses on, until they extend to the person she loves most in the world: her son, JJ. Suddenly Laurie must face solving the crime - and saving her son's life.

Robin Cook: Cure. Macmillan; ISBN: 9780230750647 (February, 2011), 464 p., £17.99.

Robin Cook: Cure (USA 2010)

From the Publisher:
The New York Times-bestselling author and master of the medical thriller returns with another heart-pounding story of medical intrigue.
With her young son's potentially fatal neuroblastoma in complete remission, New York City medical examiner Laurie Montgomery returns to work, only to face the case of her career. The investigation into the death of CIA agent Kevin Markham is a professional challenge-and has Laurie's colleagues wondering if she still has what it takes after so much time away.

Markham's autopsy results are inconclusive, and though it appears he's been poisoned, toxicology fails to corroborate Laurie's suspicions. While her coworkers doubt her assassination theory, her determination wins over her husband, fellow medical examiner Jack Stapleton, and together they discover associations to a large pharmaceutical company and several biomedical start-ups dealing with stem-cell research. Laurie and Jack race to connect the dots before they are consumed in a dangerous game of biotech espionage.

Robin Cook: Cure. Putnam, ISBN: 9780399156625 (August, 2010), 396 p., $26.95.